ConductScience.org, home

Paper4216640

Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding.

Blake CC and 4 others. J Mol Biol, 1974. Cited by 231 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. Papers, record 4216640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4216640

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strjcture of human plasma prealbumin at 2-5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding.
PubMed
Journal
J Mol Biol
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
5.2
iCite
Revised in PubMed
2019-07-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blake CCC C
2Geisow MJM J
3Swan IDI D
4Rerat CC
5Rerat BB

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Thyroxine-Binding ProteinsMajor topic
Fourier Analysis
Humans
Mercury
Models, Structural
Molecular Weight
Peptides
Protein Conformation
Triiodothyronine
X-Ray Diffraction

Source PubMed

Download CSV of topics

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
41481737Targeting transthyretin by one Cas9 variant with superfidelity and broad compatibility.Sci Adv2026https://conductscience.org/library/papers/41481737PubMed
41474749Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41474749PubMed
37869146Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy.Front Neurol2023https://conductscience.org/library/papers/37869146PubMed
37830598Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis.Cells2023https://conductscience.org/library/papers/37830598PubMed
36555787Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.Int J Mol Sci2022https://conductscience.org/library/papers/36555787PubMed
36306808Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation.J Med Chem2022https://conductscience.org/library/papers/36306808PubMed
36302762Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis.Nat Commun2022https://conductscience.org/library/papers/36302762PubMed
36290413Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy.Biology (Basel)2022https://conductscience.org/library/papers/36290413PubMed
35889910Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Population.Nutrients2022https://conductscience.org/library/papers/35889910PubMed
35256455Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.J Neurol Neurosurg Psychiatry2022https://conductscience.org/library/papers/35256455PubMed
34443678Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment.Molecules2021https://conductscience.org/library/papers/34443678PubMed
34297165The role of transthyretin in cell biology: impact on human pathophysiology.Cell Mol Life Sci2021https://conductscience.org/library/papers/34297165PubMed
33956179Reenacting the Birth of a Function: Functional Divergence of HIUases and Transthyretins as Inferred by Evolutionary and Biophysical Studies.J Mol Evol2021https://conductscience.org/library/papers/33956179PubMed
33686575The interaction of zinc with the multi-functional plasma thyroid hormone distributor protein, transthyretin: evolutionary and cross-species comparative aspects.Biometals2021https://conductscience.org/library/papers/33686575PubMed
33362465Modulation of the Mechanisms Driving Transthyretin Amyloidosis.Front Mol Neurosci2020https://conductscience.org/library/papers/33362465PubMed
33212973Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?Int J Mol Sci2020https://conductscience.org/library/papers/33212973PubMed
31782077Amyloidosis in Heart Failure.Curr Heart Fail Rep2019https://conductscience.org/library/papers/31782077PubMed
31209302Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.Nat Rev Neurol2019https://conductscience.org/library/papers/31209302PubMed
30764529Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.Biomedicines2019https://conductscience.org/library/papers/30764529PubMed
28762097A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.Mol Neurobiol2018https://conductscience.org/library/papers/28762097PubMed

See all 51 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TTR7276Swiss-Prot's referenceshttps://conductscience.org/library/genes/7276

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4216640

GET https://conductscience.org/api/papers/v1/4216640/cited_by?page=2